학술논문

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
Document Type
Article
Source
In The Lancet 24-30 June 2017 389(10088):2473-2481
Subject
Primary Research
Articles
Language
ISSN
0140-6736